A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD2.44
- USD2.48
- USD2.20
- USD4.40
- -22.90%
- --
- 21.63k
- 33M
- 1.08
- -26.90%
Stock News
6 hours ago
Google gets new head of search and ad business as part of AI-focused reshuffling
MarketWatch
6 hours ago
Jim Cramer On Oracle Corporation (ORCL): ‘I Like The Prospects’
Yahoo
6 hours ago
Warren Buffett's Strategic Reduction in Bank of America Holdings
Yahoo
7 hours ago
Flowserve: More Room To Run Despite The Stock's Recent Rally
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
